Urologic Oncology-seminars And Original Investigations

Urologic Oncology-seminars And Original Investigations

泌尿肿瘤学研讨会和原始研究

  • 3区 中科院分区
  • Q2 JCR分区

期刊简介

《Urologic Oncology-seminars And Original Investigations》是由Elsevier Inc.出版社于1995年创办的英文国际期刊(ISSN: 1078-1439,E-ISSN: 1873-2496),该期刊长期致力于泌尿学与肾脏学领域的创新研究,主要研究方向为医学-泌尿学与肾脏学。作为SCIE收录期刊(JCR分区 Q2,中科院 3区),本刊采用OA未开放获取模式(OA占比0.0355...%),以发表泌尿学与肾脏学领域等方向的原创性研究为核心(研究类文章占比91.43%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在245篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Urologic Oncology-seminars And Original Investigations审稿周期约为 偏慢,4-8周 约7.6周。该刊近年未被列入国际预警名单,年发文量约245篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 245 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
3区
UROLOGY & NEPHROLOGY 泌尿学与肾脏学 ONCOLOGY 肿瘤学
3区 4区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
3区
UROLOGY & NEPHROLOGY 泌尿学与肾脏学 ONCOLOGY 肿瘤学
3区 4区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q3 193 / 322

40.2%

学科:UROLOGY & NEPHROLOGY SCIE Q2 46 / 126

63.9%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q2 130 / 322

59.78%

学科:UROLOGY & NEPHROLOGY SCIE Q2 48 / 126

62.3%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:4.8 SJR:0.867 SNIP:0.802
学科类别 分区 排名 百分位
大类:Medicine 小类:Urology Q1 28 / 120

77%

大类:Medicine 小类:Oncology Q2 177 / 404

56%

期刊发文

  • Clinical significance of functional and anatomical classifications in paraganglioma of the urinary bladder

    Author: Hongyan Lu, Musa Male, Kehua Jiang, Zhangqun Ye, Dongkui Song, Ding Xia

    Journal: UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2019, Vol., , DOI:10.1016/j.urolonc.2019.01.027

  • The TERT locus genotypes of rs2736100-CC/CA and rs2736098-AA predict shorter survival in renal cell carcinoma

    Author: Runzhuo Ma, Cheng Liu, Min Lu, Xiaotian Yuan, Guanghui Cheng, Feng Kong, Jian Lu, Klas Strååt, Magnus Björkholm, Lulin Ma, Dawei Xu

    Journal: UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2019, Vol., , DOI:10.1016/j.urolonc.2019.01.014

  • RPS7 promotes cell migration through targeting epithelial-mesenchymal transition in prostate cancer

    Author: Yingwu Wen, Zesheng An, Baomin Qiao, Changwen Zhang, Zhihong Zhang

    Journal: UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2019, Vol., , DOI:10.1016/j.urolonc.2019.01.011

  • The prognostic value of the site of invasion in T3aN0M0 clear cell renal cell carcinoma

    Author: Shengjie Guo, Zefu Liu, Xiangdong Li, Kai Yao, Pei Dong, Dong Chen, Chunxian Liao, Zhaolin Long, Yongqiang Wang, Fangjian Zhou, Xiaobo He, Zhuowei Liu

    Journal: UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2019, Vol., , DOI:10.1016/j.urolonc.2019.01.019

  • Antitumor effect of a dual cancer-specific oncolytic adenovirus on prostate cancer PC-3 cells

    Author: Chuan-xin Cui, Yi-quan Li, Yu-jia Sun, Yi-long Zhu, Jin-bo Fang, Bing Bai, Wen-jie Li, Shan-zhi Li, Yi-zhen Ma, Xiao Li, Wei-hua Wang, Ning-yi Jin

    Journal: UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2019, Vol., , DOI:10.1016/j.urolonc.2018.12.012

  • Development and external validation of a nomogram predicting prognosis of upper tract urothelial carcinoma after radical nephroureterectomy

    Author: Shuxiong Zeng, Lihe Dai, Jun Yang, Xiaomin Gao, Xiaowen Yu, Qian Ren, Kaijian Wang, Jinshan Xu, Zeyu Yang, Bo Yang, Huiqing Wang, Qing Yang, Huamao Ye, Jianguo Hou, Yue Pan, Zhensheng Zhang, Zhiliang Weng, Yinghao Sun, Chuanliang Xu

    Journal: UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2019, Vol., , DOI:10.1016/j.urolonc.2018.12.027

  • Metabolic syndrome and upper tract urothelial carcinoma: A retrospective analysis from a large Chinese cohort

    Author: Hang Xu, Ping Tan, Xiaonan Zheng, Jianzhong Ai, Tianhai Lin, Xi Jin, Lina Gong, Haoran Lei, Lu Yang, Qiang Wei

    Journal: UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, Vol., , DOI:10.1016/j.urolonc.2018.12.005

  • Preoperative apolipoprotein B/A1 ratio is an independent prognostic factor in metastatic renal cell carcinoma

    Author: Fan Zhang, Yongpeng Xie, Xin Ma, Liangyou Gu, Hongzhao Li, Xintao Li, Gang Guo, Xu Zhang

    Journal: UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, Vol., , DOI:10.1016/j.urolonc.2018.11.010